94 -5 (79) 2025 - Makhmudova L.I., Abdullaev I.A. - SYMPTOM-BASED SEVERITY CLASSIFICATION IN IRRITABLE BOWEL SYNDROME

SYMPTOM-BASED SEVERITY CLASSIFICATION IN IRRITABLE BOWEL SYNDROME

Makhmudova L.I. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Abdullaev I.A. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

The scientific article summarizes the survey data of 90 patients with IBS who were examined in the polyclinic department of the Bukhara Regional Multidisciplinary Medical Center from 2022 to 2023. The average age of the patients was 33.3±1.5 years. With mild IBS, all patients had abdominal pain syndrome (100%), diarrhea syndrome - in 18.7%, constipation syndrome - in 81.3%, bloating - in 96.9%, a feeling of incomplete bowel movements - in 9.4%, false urges - in 6.3%, mucus secretion - in 15.6%, prolonged strain during defecation occurred in 46.9%. In contrast to the mild form of IBS, the moderate form of IBS was characterized by diarrhea in 54.1%, constipation in 45.9%, a feeling of incomplete bowel movements in 37.8%, and prolonged strain during bowel movements in 59.4%. In severe IBS, there was a significant increase in the proportion of patients with clinical signs such as diarrhea, bloating, feeling of incomplete bowel movements, false urges, mucus secretion, and prolonged strain during bowel movements. (80.9%, 100%, 71.4%, 19.1%, 33.3% and 85.7%, respectively).

Keywords: irritable bowel syndrome, abdominal pain, Bristol scale, diarrhea, constipation.

First page

471

Last page

474

For citation:Makhmudova L.I., Abdullaev I.A. - SYMPTOM-BASED SEVERITY CLASSIFICATION IN IRRITABLE BOWEL SYNDROME//New Day in Medicine 5(79)2025 471-474 https://newdayworldmedicine.com/en/new_day_medicine/5-79-2025

List of References

  1. Ivashkin V.T., Zolnikova O.Yu. Irritated Intestinal Syndrome from the Perspective of Changes in the Microbiota. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2019; 29 (1): 84-92. https://doi.org/10.22416/1382-4376-2019-29-1-84-92.
  2. Ivashkin V.T., Ivashkin K.V. Intestinal microbiome as a factor in regulating the activity of the enteral and central nervous systems. Rose journal gastroenterol hepatol coloproctol. 2017; 27 (5): 11-9.
  3. Kovaleva A.L., Poluektova E.A., Shifrin O.S. Intestinal barrier, intestinal permeability, nonspecific inflammation and their role in the formation of functional diseases of the gastrointestinal tract. Russian Gastroenterological Association for the diagnosis and treatment of gastroesophageal reflux disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2020; 30 (4):52-59. https://doi.org/10.22416/1382- 4376-2020-30-4-52-59.
  4. Vanheel H., Vicario M., Vanuytsel T., Tack J.F., Farre R. Eosinophils and mast cells in functional dyspepsia: ultrastructural evaluation of activation. Gastroenterology. 2015;148:S49.
  5. Martinez C., Lobo B., Pigrau M., Ramos L., Gonzalez Castro A.M., Alonso C., et al. Diarrhoea-dominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier. Gut. 2013; 62:1160-8. DOI: 10.1136/gutjnl-2012-302093.

    file

    download